Literature DB >> 32482652

Is Macrophage Activation Syndrome in Kawasaki Disease Underrecognized?

Valentina Natoli1, Silvia Rosina2, Angelo Ravelli3.   

Abstract

Entities:  

Year:  2020        PMID： 32482652     DOI： 10.3899/jrheum.200361

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome.

Authors:  Grazia Bossi; Alessia Claudia Codazzi; Federica Vinci; Edoardo Clerici; Corrado Regalbuto; Carmela Crapanzano; Daniele Veraldi; Alice Moiraghi; Gian Luigi Marseglia
Journal:  Children (Basel)       Date:  2022-05-05

Review 2.  Immune cartography of macrophage activation syndrome in the COVID-19 era.

Authors:  Dennis McGonagle; Athimalaipet V Ramanan; Charlie Bridgewood
Journal:  Nat Rev Rheumatol       Date:  2021-02-05       Impact factor: 32.286

Review 3.  Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.

Authors:  Chetan Sharma; Madhusudan Ganigara; Caroline Galeotti; Joseph Burns; Fernando M Berganza; Denise A Hayes; Davinder Singh-Grewal; Suman Bharath; Sujata Sajjan; Jagadeesh Bayry
Journal:  Nat Rev Rheumatol       Date:  2021-10-29       Impact factor: 20.543

4.  Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?

Authors:  Caterina Matucci-Cerinic; Roberta Caorsi; Alessandro Consolaro; Silvia Rosina; Adele Civino; Angelo Ravelli
Journal:  Front Pediatr       Date:  2021-06-04       Impact factor: 3.418

5.  Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France.

Authors:  Julie Toubiana; Jérémie F Cohen; Joséphine Brice; Clément Poirault; Fanny Bajolle; William Curtis; Florence Moulin; Soraya Matczak; Marianne Leruez; Jean-Laurent Casanova; Martin Chalumeau; Melissa Taylor; Slimane Allali
Journal:  J Clin Immunol       Date:  2021-01-04       Impact factor: 8.317
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.